Achillion Pharma (ACHN) Misses Q4 EPS by 1c

Achillion Pharma (NASDAQ: ACHN) reported Q4 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

GUIDANCE:

Achillion Pharma sees FY2018 EPS of ($0.58)-($0.55), versus the consensus of ($0.71).

For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M